Literature DB >> 31775595

Potential Therapeutic Applications of C-Phycocyanin.

Saira M Bannu1, Dakshayani Lomada2, Surendra Gulla1, Thummala Chandrasekhar3, Pallu Reddanna4, Madhava C Reddy1.   

Abstract

BACKGROUND: Cancer and other disorders such as inflammation, autoimmune diseases and diabetes are the major health problems observed all over the world. Therefore, identifying a therapeutic target molecule for the treatment of these diseases is urgently needed to benefit public health. C-Phycocyanin (C-PC) is an important light yielding pigment intermittently systematized in the cyanobacterial species along with other algal species. It has numerous applications in the field of biotechnology and drug industry and also possesses antioxidant, anticancer, antiinflammatory, enhanced immune function, including liver and kidney protection properties. The molecular mechanism of action of C-PC for its anticancer activity could be the blockage of cell cycle progression, inducing apoptosis and autophagy in cancer cells.
OBJECTIVES: The current review summarizes an update on therapeutic applications of C-PC, its mechanism of action and mainly focuses on the recent development in the field of C-PC as a drug that exhibits beneficial effects against various human diseases including cancer and inflammation.
CONCLUSION: The data from various studies suggest the therapeutic applications of C-PC such as anti-cancer activity, anti-inflammation, anti-angiogenic activity and healing capacity of certain autoimmune disorders. Mechanism of action of C-PC for its anticancer activity is the blockage of cell cycle progression, inducing apoptosis and autophagy in cancer cells. The future perspective of C-PC is to identify and define the molecular mechanism of its anti-cancer, anti-inflammatory and antioxidant activities, which would shed light on our knowledge on therapeutic applications of C-PC and may contribute significant benefits to global public health. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  C-Phycocyanin; cancer; cell death; inflammation; public health; therapeutic agent.

Mesh:

Substances:

Year:  2019        PMID: 31775595     DOI: 10.2174/1389200220666191127110857

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  4 in total

1.  Combination of Phycocyanin, Zinc, and Selenium Improves Survival Rate and Inflammation in the Lipopolysaccharide-Galactosamine Mouse Model.

Authors:  Pinar Oner; Besir Er; Cemal Orhan; Kazim Sahin
Journal:  Biol Trace Elem Res       Date:  2022-09-29       Impact factor: 4.081

Review 2.  A Fundamental Role for Oxidants and Intracellular Calcium Signals in Alzheimer's Pathogenesis-And How a Comprehensive Antioxidant Strategy May Aid Prevention of This Disorder.

Authors:  Mark F McCarty; James J DiNicolantonio; Aaron Lerner
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

Review 3.  Phycobiliproteins: Structural aspects, functional characteristics, and biotechnological perspectives.

Authors:  Jorge Dagnino-Leone; Cristina Pinto Figueroa; Mónica Latorre Castañeda; Andrea Donoso Youlton; Alejandro Vallejos-Almirall; Andrés Agurto-Muñoz; Jessy Pavón Pérez; Cristian Agurto-Muñoz
Journal:  Comput Struct Biotechnol J       Date:  2022-02-23       Impact factor: 7.271

4.  C-phycocyanin alleviated cisplatin-induced oxidative stress and inflammation via gut microbiota-metabolites axis in mice.

Authors:  Yubing Zhang; Lili Li; Song Qin; Jingyi Yuan; Xiaonan Xie; Fan Wang; Shanliang Hu; Yuetao Yi; Min Chen
Journal:  Front Nutr       Date:  2022-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.